Primary study · included by 1 review
Randomized Placebo-Controlled and Controlled Non-Inferiority Phase III Trials Comparing Trafermin, a Recombinant Human Fibroblast Growth Factor 2, and Enamel Matrix Derivative in Periodontal Regeneration in Intrabony Defects
Kitamura 2016 · Kitamura Masahiro, Akamatsu Motoki, Kawanami Masamitsu, et al. · Journal of Bone and Mineral Research · 2015
Included by
The review does not say which of its outcomes this study informs.
1 including review in total.